Kyle Lefkoff, Director at MIRAGEN THERAPEUTICS, INC. (MGEN), sold 5,800 shares at $14.31 ($83K) on 2017-03-10, disclosed to the SEC on 2017-03-13.
Open-market sale of $83k MGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.38 | 2,500 | $36K | 43.2% |
| 2 | $14.31 | 3,300 | $47K | 56.8% |
| Total | $14.34 avg | 5,800 | $83K | 100% |
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |